newsfilter
← Latest News
GlobeNewswire·

Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026

FOSTER CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today